NASDAQ: ANIK
Anika Therapeutics Inc Stock Ownership - Who owns Anika Therapeutics?

Insider buying vs selling

Have Anika Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen D. GriffinEVP CFO COO2025-06-033,769$11.59
$43.68kSell
Cheryl R. BlanchardPresident CEO Director2025-03-1712,152$15.91
$193.34kSell
Anne NunesSVP Chief Operations Officer2025-03-171,068$15.91
$16.99kSell
David ColleranEVP General Counsel Corp Sec2025-03-171,893$15.91
$30.12kSell
David ColleranEVP General Counsel Corp Sec2025-03-112,250$16.79
$37.78kSell
Cheryl R. BlanchardPresident CEO Director2025-03-1112,675$16.79
$212.81kSell
Anne NunesSVP Chief Operations Officer2025-03-11752$16.79
$12.63kSell
Cheryl R. BlanchardPresident CEO Director2025-03-105,871$16.62
$97.58kSell
Anne NunesSVP Chief Operations Officer2025-03-10959$16.62
$15.94kSell
David ColleranEVP General Counsel Corp Sec2025-03-101,604$16.62
$26.66kSell

1 of 1

ANIK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIK insiders and whales buy or sell their stock.

ANIK Shareholders

What type of owners hold Anika Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.08%1,741,762$17.99MInstitution
Trigran Investments Inc11.24%1,621,215$16.75MInstitution
Caligan Partners LP9.95%1,435,130$14.82MInstitution
Farmaceutici Spa Fidia9.86%1,422,384$14.69MInsider
Vanguard Group Inc5.41%780,663$8.06MInstitution
Acadian Asset Management LLC4.39%632,791$6.54MInstitution
Dimensional Fund Advisors LP4.17%601,163$6.21MInstitution
Capital Management Corp3.82%551,248$5.69MInstitution
Boothbay Fund Management LLC3.74%539,642$5.57MInstitution
Renaissance Technologies LLC3.70%533,017$5.51MInstitution

1 of 3

ANIK vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIK82.11%17.89%Net Selling
LNSR39.88%50.62%Net SellingNet Selling
NNOX19.34%0.01%Net Buying
APYX41.15%21.82%Net BuyingNet Buying
QIPT47.08%16.44%Net BuyingNet Buying

Anika Therapeutics Stock Ownership FAQ

Who owns Anika Therapeutics?

Anika Therapeutics (NASDAQ: ANIK) is owned by 84.82% institutional shareholders, 18.48% Anika Therapeutics insiders, and 0.00% retail investors. Farmaceutici Spa Fidia is the largest individual Anika Therapeutics shareholder, owning 1.42M shares representing 9.86% of the company. Farmaceutici Spa Fidia's Anika Therapeutics shares are currently valued at $14.58M.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.